PLAY PODCASTS
Episode 248: Edwin Kwan: D-Link Wi-Fi Device Vulnerable to Command Injection Attack; Katy Craig: Google Goes Passwordless; Hillary Coover: FDA Adapting to AI: Balancing Innovation and Safety; Marcel Brown: This Day, October 11th, in Tech History
Season 1 · Episode 248

Episode 248: Edwin Kwan: D-Link Wi-Fi Device Vulnerable to Command Injection Attack; Katy Craig: Google Goes Passwordless; Hillary Coover: FDA Adapting to AI: Balancing Innovation and Safety; Marcel Brown: This Day, October 11th, in Tech History

It's 5:05! Daily cybersecurity and open source briefing

October 11, 20238m 28s

Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Free, ungated access to all 245+ episodes of “It’s 5:05!” on your favorite podcast platforms: https://bit.ly/505-updates. You’re welcome to 𝗿𝗲𝗽𝗼𝘀𝘁 if your followers will find this of value.

The stories we’re covering today.

Marcel Brown: October 11, 1887. Dorr Eugene Felt is granted the second of two patents on his comptometer, the first practical and commercially successful key-driven, mechanical calculator. Various comptometers were in continuous production from 1887 to the mid 1970s.

Edwin Kwan: A popular D-Link WiFi range extender device is susceptible to remote command injection, and there is currently no fix available. The researchers reached out to D-Link to report the flaw in May 2023, but despite multiple follow ups, did not receive any replies.

Katy Craig:  Google is taking a significant step towards enhancing online security by making 'passkeys' the default login method on its platforms. Passkeys are digital credentials stored on a user's device, eliminating the need to remember passwords and offering a more secure alternative.

Hillary Coover: Can the FDA keep pace with the rapidly evolving world of AI in healthcare? As developers incorporate more advanced AI systems with human-like outputs, debates around FDA regulation are going to intensify.